CTLA4 and neoplasm: The ACC tumour microenvironment shows low levels of CD8+ tumour infiltrating lymphocytes, PD‐1 and cytotoxic T lymphocytes antigen 4 (CTLA‐4) positive cells and overexpresses immune inhibitors such as PD‐L2, but not PD‐L1 [2].